Immunology:
Our other therapy areas

    • {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}
      • Humira logo
      Humira logo
      About Humira
      Presentation & Dosing
      Pen Design
      Services
      Resources

      PRESENTATION & DOSING

      DOWNLOAD THE HUMIRA PRESCRIBING GUIDEDownload the HUMIRA Prescribing Guide

      Presentation1

      decorative

      HUMIRA pre-filled syringe
      20mg

      decorative

      HUMIRA pre-filled pen and syringe
      40mg

      decorative

      HUMIRA pre-filled pen and syringe
      80mg

      Citrate-free, low volume formulation - 80mg presentation redesigned pen

      Dosing1

      HUMIRA Dosing
      Click for a large view

       *80 mg and 40 mg presentations available for patients with Crohn’s disease or ulcerative colitis and can be prescribed based on prescriber and patient preference. 80 mg presentation may enhance patient convenience with a reduced injection number vs 40 mg in induction dosing. #Depending on patient preference, the first loading dose may be split into 80 mg on Day 1 and 80 mg on Day 2. ‡HUMIRA pre-filled syringe only. §Some patients may benefit from increasing the dosage if a disease flare or an inadequate response is experienced during maintenance dosing. 
      • <40 kg: 20 mg every week • ≥40 kg: 40 mg every week or 80 mg fortnightly

      Contact a representative
      Contact a representative

      More for you

      AbbVie Care

      AbbVie Care
      How to enrol your patients on HUMIRA
       

      Therapeutic Drug Monitoring

      Therapeutic Drug Monitoring (TDM)
      TDM for your clinical toolkit and 
to support QUM

      Rinvoq

      About RINVOQ

       

      References: 1. HUMIRA Product Information.

      PBS Information

      HUMIRA: Authority required. Refer to PBS Schedule for full authority information. This product is not listed on the PBS for the treatment of enthesitis-related arthritis or paediatric psoriasis.

      Please review the full Product Information (PI) before prescribing, available below.

      HUMIRA PI

      AU-HUM-210214. October 2024